The α5β1 Integrin Mediates Elimination of Amyloid-β Peptide and Protects Against Apoptosis
Open Access
- 18 May 1998
- journal article
- Published by Rockefeller University Press in The Journal of cell biology
- Vol. 141 (4) , 1019-1030
- https://doi.org/10.1083/jcb.141.4.1019
Abstract
The amyloid-β peptide (Aβ) can mediate cell attachment by binding to β1 integrins through an arg-his-asp sequence. We show here that the α5β1 integrin, a fibronectin receptor, is an efficient binder of Aβ, and mediates cell attachment to nonfibrillar Aβ. Cells engineered to express α5β1 internalized and degraded more added Aβ1-40 than did α5β1-negative control cells. Deposition of an insoluble Aβ1-40 matrix around the α5β1-expressing cells was reduced, and the cells showed less apoptosis than the control cells. Thus, the α5β1 integrin may protect against Aβ deposition and toxicity, which is a course of Alzheimer's disease lesions.Keywords
This publication has 55 references indexed in Scilit:
- Interaction of Apolipoprotein J-Amyloid β-Peptide Complex with Low Density Lipoprotein Receptor-related Protein-2/MegalinJournal of Biological Chemistry, 1997
- Rapid cellular uptake of Alzheimer amyloid βA4 peptide by cultured human neuroblastoma cellsFEBS Letters, 1996
- Microglial Cells Internalize Aggregates of the Alzheimer's Disease Amyloid β-Protein Via a Scavenger ReceptorNeuron, 1996
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996
- Expression of the Integrin α5 Subunit in HT29 Colon Carcinoma Cells Suppresses Apoptosis Triggered by Serum DeprivationExperimental Cell Research, 1996
- Expression and distribution of functional intergrins in rat CNS gliaJournal of Neuroscience Research, 1994
- Anatomical Localization of β1 Integrin-like Immunoreactivity in Rat BrainExperimental Neurology, 1993
- The carboxy terminus of the .beta. amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's diseaseBiochemistry, 1993
- Alternative Splicing of Fibronectin Pre‐mRNA during AgingaAnnals of the New York Academy of Sciences, 1992
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984